[Meningosis in Hand-Schüller-Christian disease]

[Clinical comments on genetic marker prevalence (factor V Leiden, prothrombin 20210A and homozygous methylenetetrahydrofolate reductase form [Ho-MTHFR]): based on a study conducted in Health Department No. 19 of the Valencian Community].

Revista clinica espanola·2007

[Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2004

[Abnormalities in coagulation and fibrinolysis in septic shock with purpura].

Anales espanoles de pediatria·2002

[Thrombogenic and endothelial damage markers in patients with ischemic systolic impairment].

Revista espanola de cardiologia·2001

[Perioperative transfusion of erythrocyte concentrates during elective surgery: introduction of a protocol for indications].

Sangre·2000

[Tissue plasminogen activator as a prognostic factor in myocardial infarct patients].

Revista clinica espanola·1999

Stickler syndrome type 1: case series and new genetic variants.

Revista clinica espanola·2026

Executive summary of the consensus document for recommendations on the treatment of venous thromboembolism in pregnancy: Consensus document from the Spanish Society of Internal Medicine, the Spanish Society of Medical Radiology, the Spanish Society of Vascular Interventional Radiology and the Spanish Society of Gynecology and Obstetrics 2026.

Revista clinica espanola·2026

Treatment of osteoporosis in clinical practice: When, whom, how, and for how long.

Revista clinica espanola·2026

Metabolic alkalosis and clinical outcomes in acute heart failure: a systematic review and meta-analysis.

Revista clinica espanola·2026

Pulmonary embolism: what does the new AHA/ACC 2026 guide add.

Revista clinica espanola·2026

Training in internal medicine in the age of artificial intelligence.

Revista clinica espanola·2026

Ex Vivo Perfusion Unmasks a Proteomic Signature of Primary Graft Dysfunction in Donor Hearts.

JACC. Heart failure·2026

Thrombin-Antithrombin Complexes and sICAM-1 Are Associated With In-Hospital Mortality in COVID-19 Patients With Inflammatory Storm.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

CYP2C19 Genetic Variability, ADP-Induced Whole-Blood Platelet Aggregation, and Clopidogrel Response in an Exploratory Retrospective Cohort of Acute Ischemic Stroke.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

Medication persistence and mortality in ST-elevation myocardial infarction patients with and without standard modifiable risk factors: a SWEDEHEART registry study.

European journal of preventive cardiology·2026

Impact of chronic kidney disease on long-term outcomes after left main percutaneous coronary intervention: a propensity score-matched analysis with up to 10 years of follow-up.

Polish archives of internal medicine·2026

Anticoagulation in Advanced Chronic Kidney Disease: Navigating Uncertainty.

Turkish journal of haematology : official journal of Turkish Society of Haematology·2026

Related Experiment Videos

[Meningosis in Hand-Schüller-Christian disease]

Related Concept Videos

[Clinical comments on genetic marker prevalence (factor V Leiden, prothrombin 20210A and homozygous methylenetetrahydrofolate reductase form [Ho-MTHFR]): based on a study conducted in Health Department No. 19 of the Valencian Community].

[Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].

[Abnormalities in coagulation and fibrinolysis in septic shock with purpura].

[Thrombogenic and endothelial damage markers in patients with ischemic systolic impairment].

[Perioperative transfusion of erythrocyte concentrates during elective surgery: introduction of a protocol for indications].

[Tissue plasminogen activator as a prognostic factor in myocardial infarct patients].

Stickler syndrome type 1: case series and new genetic variants.

Treatment of osteoporosis in clinical practice: When, whom, how, and for how long.

Metabolic alkalosis and clinical outcomes in acute heart failure: a systematic review and meta-analysis.

Pulmonary embolism: what does the new AHA/ACC 2026 guide add.

Training in internal medicine in the age of artificial intelligence.

Ex Vivo Perfusion Unmasks a Proteomic Signature of Primary Graft Dysfunction in Donor Hearts.

Thrombin-Antithrombin Complexes and sICAM-1 Are Associated With In-Hospital Mortality in COVID-19 Patients With Inflammatory Storm.

CYP2C19 Genetic Variability, ADP-Induced Whole-Blood Platelet Aggregation, and Clopidogrel Response in an Exploratory Retrospective Cohort of Acute Ischemic Stroke.

Medication persistence and mortality in ST-elevation myocardial infarction patients with and without standard modifiable risk factors: a SWEDEHEART registry study.

Impact of chronic kidney disease on long-term outcomes after left main percutaneous coronary intervention: a propensity score-matched analysis with up to 10 years of follow-up.

Anticoagulation in Advanced Chronic Kidney Disease: Navigating Uncertainty.

Related Experiment Videos

[Meningosis in Hand-Schüller-Christian disease]

Related Concept Videos

Related Articles